Project Grant HT94252410099
- The Department of the Army Medical Command awarded a $1,724,662 Project Grant to the University of Wisconsin-Madison under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to identify neuronal signatures that distinguish Fragile X syndrome patients exhibiting distinct electroencephalogram phenotypes. The University of Wisconsin System, doing business as Research and Sponsored Programs, will perform the work over a four-year period ending July...
- The Department of the Army Medical Command awarded a $1,324,049 Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to identify neuronal signatures that distinguish Fragile X syndrome (FXS) patients with distinct electroencephalogram (EEG) phenotypes. The four-year award beginning August 1, 2022 will support research to investigate medical solutions for the battlefield by transforming healthcare through innovative...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- The University of Florida Division of Sponsored Research was awarded a $745,408 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias" over a 4-year period through March 31, 2028. This research aims to advance the understanding and...
- The Department of the Army Medical Command awarded a $384,001 Project Grant to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2022 to February 29, 2024 to investigate the neural circuit mechanisms of stress-induced insomnia and metabolic dysfunction. Through its support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
- The University of Florida (UF) Division of Sponsored Research has been awarded a $2,235,400 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The award, effective April 1, 2024 through March 31, 2028, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias." This project grant is part of the Military Medical Research and Development program, which...
- This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
- The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This $315,958 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Rush University Medical Center to investigate the neural underpinnings of the relationship between cognitive and gait dysfunction in Fragile X-associated Tremor/Ataxia Syndrome (FXTAS). The award period runs from September 30, 2024 to September 29, 2026. This research aims to transform health care for service members and the American public through innovative and impactful studies on neurological disorders. The Military Medical Research and Development program frequently funds grants to academic medical centers and research universities for projects with the potential to make significant advances in military medicine.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 3/14/24 | ||
| Not listed | $316.0k | 1/19/24 |